Better Care

Achieve a new standard of personalized care.

Precision medicine is driving the future of healthcare—and Prescient Medicine is delivering the tools that define the movement. We believe that with deeper predictive insights, tomorrow’s caregivers and researchers can make better decisions than ever before.

Our commitment extends to the physicians we support and the research partners we serve — because we know that this future will be shaped by the caliber of methodologies available to both providers and industry businesses. Through our expertise in pharmacology, chemistry, in vitro diagnostics (IVD), pathology, pharmacogenomics, and toxicology, we’ve created powerful tests and analytics that deliver the information necessary to make the right choice at the right time.

Understanding the vital role our industry partners will play in shaping the future of medicine, we’ve spent decades cultivating key relationships with medical researchers and organizations. Our years of experience with major IVD companies have laid the foundation for our innovative strategies, which we deliver with unmatched professionalism and a security-focused mindset.

The stakes are high, so our testing standards far exceed the status quo. Our on-site protocols are conducted by seasoned technicians who ensure that our data is reliable and quality controlled. The resulting reports are built to be highly useful within a fast-paced workflow: fully customizable and easily digestible, enabling rapid prioritization and decision making.

With our innovative tools and strategic expertise, we’re opening doors for the entire medical community. Physicians can capitalize on their ability to make the most informed therapeutic decisions, and prescribe with the highest possible confidence. Industry partners can take advantage of our depth of professional experience and harness the power of our advanced analytics to break new ground. By replacing trial and error with insight and certainty, Prescient is delivering the future. We’re defining better care.

Personalized Care

No two patients metabolize a drug the same way. Let’s make that your advantage. Our pharmacogenomic testing platform can be immediately adopted into your patient treatment regimen.

Identify Drug Interactions — In Advance

ADRs are costly. Our toxicology and medication monitoring solutions provide the clarity you need to move beyond possible complications.

Uncover Critical Insights

With over 40 years of combined experience with major IVD companies, we offer a wealth of knowledge in clinical trials, research & development, and custom analysis.

Better Data Means Better Care

Our big data infrastructure delivers the kinds of intelligent, customized analytics healthcare today demands. And our ever-evolving diagnostic design procedures, kits and apps keep our industry-leading portfolio growing.

Patient Services

Provide for your patients’ individual needs with the billing system that’s most convenient for each client. We bill all commercial insurance plans and Medicare, or can offer our services on a fee-for-service basis.

20% of hospital readmissions are attributed to Adverse Drug Reactions (ADRs)1

1. Davies EC, Green CF, Mottram DR, Rowe PH, Pirmohamed M. Emergency re-admissions to hospital due to adverse drug reactions within 1 year of the next index admission. Br J Clin Pharmacol. 2010 Nov; 70(5): 749–755. PMCID: PMC2997315.